Jardiance (empagliflozin) is a brand-name drug that’s prescribed for type 2 diabetes and more. As with other drugs, Jardiance can cause side effects, such as vaginal yeast infections and urinary tract ...

SAN DIEGO — The significant kidney and cardiovascular benefits people with chronic kidney disease (CKD) show over 2 years of treatment with empagliflozin begin to subside within about a year after ...

THURSDAY, June 26, 2025 (HealthDay News) -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial ...

Jardiance is a diabetes medication that manages blood glucose levels, it is also used as a weight loss treatment. The active drug, Empagliflozin, although not technically a weight loss medication, ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

The FDA has approved new oral therapies for children with type 2 diabetes — empagliflozin and a combination of empagliflozin and metformin hydrochloride — for the first time in more than 20 years. The ...

MONDAY, Oct. 27, 2025 (HealthDay News) -- Intranasal insulin (INI) and empagliflozin are safe and have promising effects on cognition, according to a study published online Oct. 7 in Alzheimer's & ...

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function. (HealthDay News) — Empagliflozin has kidney protective effects and reduces ...